MARKET

NRSN

NRSN

Neurosense Therapeutics Ltd
NASDAQ
0.4531
+0.0100
+2.26%
After Hours: 0.4823 +0.0292 +6.44% 19:18 08/14 EDT
OPEN
0.4400
PREV CLOSE
0.4431
HIGH
0.4617
LOW
0.4383
VOLUME
55.52K
TURNOVER
--
52 WEEK HIGH
1.980
52 WEEK LOW
0.3930
MARKET CAP
17.11M
P/E (TTM)
-1.0378
1D
5D
1M
3M
1Y
5Y
1D
NeuroSense CEO Details Phase 3 ALS Trial Plans, Canada Filing and Nasdaq Compliance Efforts
TipRanks · 2d ago
NeuroSense Issues CEO Letter to Shareholders
PR Newswire · 2d ago
Analysts Offer Insights on Healthcare Companies: Neurosense Therapeutics Ltd. (NRSN) and Brookdale Senior Living (BKD)
TipRanks · 4d ago
Weekly Report: what happened at NRSN last week (0803-0807)?
Weekly Report · 5d ago
NeuroSense sees December 2026 as filing date for NDS for PrimeC
TipRanks · 08/06 15:35
NeuroSense Completes PrimeC Pre-NDS Process and Advances Toward December 2026 Filing with Health Canada
PR Newswire · 08/06 15:29
Weekly Report: what happened at NRSN last week (0727-0731)?
Weekly Report · 08/03 09:49
NeuroSense Updates Capital on Demand Program After New F-3 Becomes Effective
TipRanks · 07/31 20:48
More
About NRSN
NeuroSense Therapeutics Ltd. is an Israel-based clinical-stage pharmaceutical company engaged in the development of therapies for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The Company’s lead product candidate, PrimeC, is an oral fixed-dose combination therapy designed for the treatment of ALS. In addition to PrimeC, the Company conducts research and development activities focused on neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease. The Company develops pharmaceutical products and therapeutic solutions aimed at addressing unmet medical needs in neurological diseases and related central nervous system disorders. The Company also advances therapies for rare neurological conditions.

Webull offers Neurosense Therapeutics Ltd stock information, including NASDAQ: NRSN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRSN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRSN stock methods without spending real money on the virtual paper trading platform.